Inhibition of vascular matrix metalloproteinase-9 to treat ischemic injury
US11345758B2 · kind B2 · utility
0Cited by
0References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 27, 2018 |
| Grant date | May 31, 2022 |
| Priority date | — |
| Expiry date | Jun 27, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/24035
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and pharmaceutical compositions for treating ischemic injury are provided. The methods include administering a therapeutically effective amount of a vascular matrix metalloproteinase 9 (MMP-9) inhibitor that reduces ischemic injury in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.